The Beacon | Kansas City covered a Missouri judge’s decision to strike down 2022 law that prevented pharmacists from contacting patients about the efficacy of ivermectin and hydroxychloroquine in our case, Stock v. Gray.
Adam E. Schulman, the Virginia lawyer who represented the St. Louis pharmacist who was the plaintiff in the lawsuit, said his client got exactly what she was asking for: a permanent end to the law.
“She was concerned about the slippery slope of laws like this turning into things larger than one or two medications,” Schulman said
Read more at The Beacon | Kansas City.